Skip to main content
. 2020 Mar 29;21(7):2359. doi: 10.3390/ijms21072359
CsA cyclosporine A
cTnT cardiac troponin T
FS fractional shortening
hAFSC human amniotic fluid-derived stem cell
hAFSC-iPSC human amniotic fluid-derived stem cell induced pluripotent stem cell
hAFSC-iPSC-CM human amniotic fluid-derived stem cell induced pluripotent stem cell derived cardiomyocyte
hESC human embryonic stem cell
HLA human leukocyte antigen
hPSC human pluripotent stem cell
hPSC-CM human pluripotent stem cell derived cardiomyocyte
I Ca,L L-type Ca2+ current
I Na Na+ current
iPSC induced pluripotent stem cell
I-R ischemia-reperfusion
LAD left anterior descending coronary artery
LV left ventricular
LVEDD left ventricular end-diastolic diameter
LVEDS left ventricular end-diastolic volume
LVEF left ventricular ejection fraction
LVESD left ventricular end-systolic diameter
LVESV left ventricular end-systolic volume
MHC major histocompatibility complex
MI myocardial infarction
OCT-4 octamer-binding transcription factor 4
SSEA4 Nanog and stage-specific embryonic antigen-4